RecruitingNot ApplicableNCT07462351
System-integrated Point-of-Care Ultrasound in Breast Cancer Screening
Sponsor
Region Skane
Enrollment
4,800 participants
Start Date
Mar 11, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
To assess the feasibility, safety, and clinical performance of community-based breast cancer screening incorporating clinical breast exam and short-termed trained examiners performing AI-supported breast POCUS for triage in limited-resource settings.
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study tests whether AI-assisted portable ultrasound (point-of-care ultrasound, or POCUS) performed by nurses and clinical officers with short training can safely screen women for breast cancer in community settings with limited medical resources. The approach combines a standard clinical breast exam with targeted ultrasound for those with abnormal findings or symptoms, aiming to improve early detection where specialist radiology is not available. Asymptomatic women aged 30 and older and symptomatic women aged 18 and older from the community are eligible to participate. Participation involves a breast exam and, if indicated, an ultrasound scan at a community screening site, with referral for further evaluation if anything suspicious is found. This summary was generated by AI to help patients understand the study in plain language.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTAI
AI-supported POCUS for triage
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07462351
Related Trials
Genomic Services Research Program
NCT025959571 location
Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity
NCT070707652 locations
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
NCT068852031 location
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
NCT06103864316 locations
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NCT070671381 location